The 3 Best Coronavirus Stocks to Buy for Long-Term Investors – The Motley Fool

Let's face it: Some companies that are receiving a lot of hype right now about their COVID-19 programs won't have staying power. Small biotechs claiming to have a game-changing treatment on the way could run into the harsh realities of clinical testing. Diagnostic test makers with all of their chips on COVID-19 could be left in the dust a couple of years from now when the pandemic has run its course.

The stocks of such companies might be OK for traders to buy to make a quick buck in the short run. But they're unsuitable for investors seeking to generate big gains over the long run. Here are my picks for the three best coronavirus-related stocks to buy for long-term investors.

Image source: Getty Images.

Abbott Labs (NYSE:ABT) quickly rolled out several COVID-19 diagnostic tests after the coronavirus hit with full force earlier this year. Its ID NOW test, which received FDA Emergency Use Authorization (EUA) in late March, attracted significant attention because it offered the fastest results of any COVID-19 test available.

I expect that COVID-19 testing will continue to fuel sales growth for Abbott over the next few years. However, there are several more important growth drivers for the company.

Put Freestyle Libre at the top of the list. Abbott recently won FDA clearance for a new version of the continuous glucose monitoring (CGM) system that supports integration with other medical devices. My prediction is that Freestyle Libre 2 will enjoy skyrocketing consumer demand and be a resounding success for Abbott.

Wall Street analysts project that Abbott will be able to deliver average annual earnings growth of more than 10% over the next five years. I think that estimate is realistic. Throw in Abbott's reliable dividend, and you've got a blue chip stock with a COVID-19 focus that's likely to beat the total returns of the S&P 500 over the long run.

Gilead Sciences (NASDAQ:GILD) has been at the center of the coronavirus world since its antiviral drug remdesevir was first touted as a potential treatment for COVID-19. With late-stage clinical studies now supporting the safety and efficacy for remdesivir, Gilead is well positioned to remain a fixture in the fight against the novel coronavirus.

However, it's Gilead's treatment for another virus -- HIV -- that has been and will continue to be its biggest opportunity. The biotech's lineup includes multiple blockbuster HIV drugs. Gilead is evaluating a long-acting HIV therapy in phase 2 clinical studies that could be its greatest commercial success yet. Looking further down the road, the company could even have a cure for HIV on the way.

Thanks to its strategic partnership with Galapagos, Gilead is poised to make its mark in immunology. The company awaits U.S. and European regulatory approvals for filgotinib in treating rheumatoid arthritis. It also is likely to become an even bigger player in the oncology market with new indications for CAR-T therapy Yescarta potentially on the way and the acquisition earlier this year of cancer-focused biotech Forty Seven.

My view is that Gilead's COVID-19, HIV, immunology, and oncology programs will enable the big biotech to deliver solid growth over the long run. That growth will be bolstered by one of the most attractive dividends in the healthcare sector: Gilead's dividend yield currently stands at nearly 3.7%.

While lots of small biotechs have scrambled to develop COVID-19 therapies, I've kept my eyes onEli Lilly (NYSE:LLY). The big drugmaker has moved at breakneck speed with its partners to advance two COVID-19 antibody therapies into clinical studies. It's also evaluating blockbuster rheumatoid arthritis drug Olumiant and pipeline candidate LY3127804 in treating COVID-19.

I won't be surprised if Lilly achieves success with at least one of its coronavirus efforts. In the meantime, the company's diabetes drug franchise continues to rock along thanks primarily to strong sales for Jardiance and Trulicity. Lilly is also a top contender in the immunology market with Olumiant and Taltz.

The company's greatest growth opportunity, though, could be in oncology. Lilly recently announced overwhelmingly positive results from a late-stage study of Verzenio in treating early-stage breast cancer. It won FDA approval in May for Retevmo in treating lung and thyroid cancer. Cyramza also continues to pick up momentum in treating several solid tumors.

Analysts think that Lilly could deliver average annual earnings growth of nearly 13% over the next five years. That level seems quite attainable to me, considering the company's solid current lineup and promising pipeline. With Lilly's dividend yield of 1.8% included, I think the pharma stock should easily outperform the overall market's total returns over the long run.

Read more:
The 3 Best Coronavirus Stocks to Buy for Long-Term Investors - The Motley Fool

High-resolution proteins being built to fight COVID-19 – MSUToday

During the COVID-19 pandemic, MSU researchers are rising to the occasion and spearheading projects that seek to aid the international efforts to develop treatments for the virus. One such researcher is Michael Feig who is part of the Department of Biochemistry and Molecular Biology at MSU. He and his postdoc Lim Heo generated high accuracy models for the SARS-CoV-2 virus.

Seeing as these structural models were not available previously from experiment, these high accuracy models can now be used in further studies that test how certain chemicals respond to the proteins. These models are used as a starting point by other researchers for screening existing drugs or developing new drugs for their potential usage in treating COVID-19.

To read the full story and view a video with Feig, go to ICER.

Follow this link:
High-resolution proteins being built to fight COVID-19 - MSUToday

Alpacas helping UK researchers to combat COVID-19 – LEX18 Lexington KY News

LEXINGTON, Ky. (LEX 18) A team at the University of Kentucky College of Medicine is researching a possible treatment for COVID-19 and key helpers are three alpacas; Big Boy, Blue Eyes and Emperor.

Its a powerful technology that we have a UK and its something that hopefully we can develop some therapeutics with, said Wally Whiteheart, a professor in the Department of Molecular & Cellular Biochemistry.

Alpacas, along with llamas and camels, make a special kind of antibody called a nanobody. Nanobodies can be useful in cancer research and for other diseases. Researchers, led by Whiteheart and fellow professor Lou Hersh, are working with River Hill Ranch near Richmond to see what impact alpacas could have on COVID-19.

We in a sense vaccinate them, and this case with viral proteins, and we make nanobodies to those viral proteins, said Whiteheart. We can then go and purify and identify the nanobodies that bind to the virus and then test them to see if they can inhibit viral infection.

Making the nanobodies is just the first step. The team will see which, if any, can block virus infection and those candidates could move on to clinical trials.

Theres still a lot of research and testing to go, but also still a lot of hope.

The cool thing which were exploring now is the fact that you might be able to use them as a nasal spray and this actually gets them to the place where the virus is affecting lung tissue, said Whiteheart.

This isnt the first time the trio of alpacas has helped UK. Big Boy, Blue Eyes and Emperor have contributed to the universitys nanobody research for more than three years. In those years, they have helped researchers generate more than 50 nanobodies to target proteins involved in a variety of human diseases including cancer, diabetes and neurological disorders.

Read more:
Alpacas helping UK researchers to combat COVID-19 - LEX18 Lexington KY News

Bench-Top Veterinary Biochemistry Analyzers Market study with COVID-19 Impact Research, Major Players, Analysis, Industry Demand by Segmentation and…

The Bench-Top Veterinary Biochemistry Analyzers Market report market intelligence study intended to offer complete understanding of global market scenario with the Impact of COVID-19 (Corona Virus). It attempts to analyze the major components of the Market which have greater influence on it. This includes various elements of significant nature including market overview, segmentation, competition landscape, Market chain analysis, key players strategyand more. Also, the report provides a 360-degree overview of global market on the basis of various analysis techniques including SWOT and Porters Five Forces. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. This might help readers to understand the strengths, opportunities, challenges and perceived threats of the market.

The following Companies are coveredin theResearch Report:Idexx LaboratoriesURIT Medical ElectronicAbaxisLITEONHeskaBPC BioSedRandox LaboratoriesDiaSys Diagnostic SystemsScil Animal CareFuji FilmAMS AllianceiCubioCarolina Liquid ChemistriesCrony Instruments

Based on Classification, each type is studied as Sales, Market Share (%), Revenue (Million USD), Price, Gross Margin and more similar information. The report can help to realize the market and strategize for business expansion accordingly. In the strategy analysis, it gives insights from marketing channel and market positioning to potential growth strategies, providing in-depth analysis for new entrants or exists competitors in the Bench-Top Veterinary Biochemistry Analyzers industry.

The Bench-Top Veterinary Biochemistry Analyzers Market report wraps:

There are 13 Chapters to thoroughly display the Bench-Top Veterinary Biochemistry Analyzers market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

In the end, The objective of the market research report is the current status of the market and in accordance classifies it into a few objects. The report takes into consideration the first market players in every area from over the globe.

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Originally posted here:
Bench-Top Veterinary Biochemistry Analyzers Market study with COVID-19 Impact Research, Major Players, Analysis, Industry Demand by Segmentation and...

Richmond Alpacas Participating In Research To Prevent COVID-19 Infection – WKMS

Alpacas from a farm near Richmond are playing a key role in work to help prevent coronavirus in humans. Three Alpacas, Big Boy, Blue Eyes, and Emperor are all part of the camelid family which produces a small, unique anti-body.

University of Kentucky Molecular and Cellular Biochemistry Professor Wally Whiteheart says the nanobodies found in the Alpacas are small enough to access small areas of the coronavirus spike proteins. The idea is you can make these as inhibitors that block function and they block the ability of the virus to get inside a cell or even bind to a cell.

If more research and federal approval proves successful, Whiteheart envisions the ultimate protection to be found through an inhaler. The alpacas have participated in UKs nanobody research for more than three years.

UK's Wally Whitehouse offers this full explanation of the COVID-19 related research with Richmond area alpacas:

View original post here:
Richmond Alpacas Participating In Research To Prevent COVID-19 Infection - WKMS

Academic’s ‘bold’ vision to save Sheffield ‘wildlife haven’ is backed by community – Yorkshire Live

An expert in biochemistry has detailed an alternative idea for how a Sheffield wildlife haven could be protected, and his "vision" for the area has been backed by a local community action group.

Councillors recently refused to allow Avant Homes to build 200 new homes on Owlthorpe Fields, land earmarked for housing for around 30 years which has since flourished with greenery and wildlife.

Dr Patrick Harrison, who was born and brought up in Waterthorpe, and is a lecturer in biochemistry at Hull University, spoke against the scheme at the planning meeting and has outlined an alternative idea.

He says the land would be better used as part of a two-mile wildlife corridor, starting at Owlthorpe Fields to the newly created wetland corridor that runs from Woodhouse Washlands to Holbrook.

It would connect the Westfield plantation, the Waterthorpe Park area which is currently being developed and Waterthorpe Meadows and Beighton ponds.

Dr Harrison said: "The premise of the corridor is born out of ideas developed for the creation of Waterthorpe Park where ecology, health and education are linked to create a space where the local community can use for their physical and mental wellbeing whilst being a giant outdoor classroom for local schools to underpin learning at all levels of the curriculum.

"It will require ambitious collaboration between various stakeholders such as Sheffield and Rotherham Wildlife Trust, community groups, schools, numerous council departments along with our universities but many of these connections are already in place.

"It now requires political will from Sheffield Council to accept the new realities of the world and the longer term benefits of such a scheme in terms of social care costs, education and biodiversity gain.

This is even more pressing in a post Covid-19 world where working arrangements will change so more people will be working and exercising in their local community.

Owlthorpe Fields Action Group, which had been set up in 2018 to oppose the Avant Homes development, have described the area as a "wildlife haven" and are backing Dr Harrison's vision for a wildlife corridor.

They have described it as "bold" and believe that it acknowledges the challenges posed by climate change, while encouraging community integration.

They said: "Its become crystal clear during the lockdown, just how important it is for residents to have access to a usable green open space on our doorsteps, for exercise, to maintain health, and perhaps even more importantly, for our peace of mind and wellbeing.

"We agree with the Council people must live somewhere, but the same goes for the animals, trees and plants living in Owlthorpe Fields. This land is not just a green field site. Its rewilded over decades, its rich in biodiversity, from the tiniest insect to buzzards flying overhead."

Owlthorpe Fields Action Group have since planned a "bio-blitz" for Saturday (June 20) where people can join them in a nature survey of the fields, which will be used to show the council how biodiverse the area is.

Members of the group will be at Owlthorpe Medical Centre at 10am, 12pm or 2pm on Saturday to meet and greet anyone who would like to take part, while adhering to social distancing regulations.

Read this article:
Academic's 'bold' vision to save Sheffield 'wildlife haven' is backed by community - Yorkshire Live

Sugar-Coating Disguise Allows for Coronavirus Infection – UC San Diego Health

According to Mary Poppins, a spoonful of sugar helps the medicine go down. In the case of coronavirus, a cloak of sugar helps the virus infect. This sugary-coating disguise, made of molecules called glycans, tricks the human immune system into identifying the microbe as harmless. The resulting recognition failure keeps the body from generating the defensive antibodies needed to destroy the invading coronavirus.

Rommie Amaro, professor of chemistry and biochemistry, UC San Diego

Using the National Science Foundation-funded Frontera supercomputer at the Texas Advanced Computing Center (TACC), Professor ofChemistry and BiochemistryRommie Amaroalong with her UC San Diego colleagues and researchers from Maynooth University in Dublin, Ireland, led by Elisa Faddahas uncovered the atomic makeup of the coronavirus's sugary cloak. The simulation and modeling reveal that glycans also prime the coronavirus for infection by changing the shape of its spike protein. Scientists hope this basic research will add to the arsenal of knowledge needed to defeat the COVID-19 virus.

The more we know about it, the more of its abilities that we're going to be able to go after and potentially take out, Amaro said. It isof such great importance that we learn as much as we can about the virus. And then hopefully we can translate those understandings into things that will be useful either in the clinic or the streets; for example, if we're trying to reduce transmission for what we know now about aerosols and wearing masks. All these things will be part of it. Basic research has a huge role to play in the war against COVID-19. And I'm happy to be a part of it. It's a strength that we have Frontera and TACC in our arsenal.

Glycans coat each of the 65-odd spike proteins that adorn the coronavirus. The sugar-like molecules account for about 40 percent of the spike protein by weight. The spike proteins are critical to cell infection because they lock onto the cell surface, giving the virus entry into the cell.

Amaro, along with her UC San Diego colleagues Lorenzo Casalino, Zied Gaieb, Abigail Dommer, Emilia Barros and Bryn Taylor, explained that even to make an initial connection, one of the pieces of the spike protein in its receptor binding domain has to lift up. It is one of the things Fronterapart of the COVID-19 HPC Consortium along with San Diego Supercomputer Center at UC San Diegohelped reveal: that in the open conformation, there are two glycans that basically prop up the spike protein.

That was really surprising to see. It's one of the major results of our study. It suggests that the role of glycans in this case is going beyond shielding to potentially having these chemical groups actually being involved in the dynamics of the spike protein, said Amaro, a corresponding author of the study published online June 12, 2020, by bioRxiv,org, a preprint repository.

Glycan shield in SARS-CoV-2 spike. (A) Molecular representation of the Open. Glycans at several frames (every 20 ns) are represented with blue lines, and the receptor binding domain within chain A is highlighted with a cyan transparent surface. (B-C) Plot of the surface area covered by glycan shielding at multiple probe radii from 1.4 (water molecule) to 15 for the head (B) and stalk (C). The area of the protein covered by the glycans is depicted in blue, while the grey line is the accessible area of the protein without glycans. Highlighted in green is the area that remains accessible in the presence of glycans, which is also graphically depicted on the structure in the panels located above the plots. Credit: Lorenzo Casalino (UC San Diego), et al.

When that receptor binding domain lifts up into the open conformation, it actually lifts the important bits of the protein up over the glycan shield, Amaro said, adding that this contrasts with the closed conformation, where the shield covers the spike protein. Our analysis gives a potential reason why it does have to undergo these conformational changes, because if it just stays in the down position those glycans are basically going to block the binding from actually happening, she said, adding that the shifts in the conformations of the glycans triggered changes in the spike protein structure.

Amaro compared the action of the glycan to pulling the trigger of a gun. When that bit of the spike goes up, the finger is on the trigger of the infection machinery. That's when it's in its most dangerous modeit is locked and loaded, Amaro said. When it gets like that, all it has to do is come up against an ACE2 receptor in the human cell, and then it's going to bind super tightly and the cell is basically infected.

The research team used computational methods to build data-centric models of the SARS-CoV-2 virus, and then used computer simulations to explore different scientific questions about the virus. They started with various experimental datasets that revealed the structure of the virus. This included cryo-EM structures from the Jason McLellan Lab of The University of Texas at Austin; and from the lab of David Veesler at the University of Washington.

Their structures are really amazing because they give researchers a picture of what these important molecular machines actually look like, Amaro said.

SARS-CoV-2 virus spike protein system overview. (A) Sequence of the full-length spike protein contains the N-terminal domain (NTD), the receptor binding domain (RBD), the furin cleavage site, the fusion peptide (FP), the central helix (CH), the connecting domain (CD), the heptad repeat 2 (HR2) domain, the transmembrane domain (TD) and the cytoplasmic tail (CT). (B) Assembly of head, stalk, and cytoplasmic tail (CT) sections into a full-length model of the spike protein (C) Equilibrated, fully glycosylated and palmitoylated model of the Open system. (C-E) Magnified view of the N-/O- glycans (C, D) and S-palmitoylation of the cytoplasmic tail (E). Image by Lorenzo Casalino, et al.

Unfortunately, even the most powerful microscopes on Earth still can't resolve movement of the protein at the atomic scale.

What we do with computers is that we take the beautiful and wonderful and important data that they give us, but then we use methods to build in missing bits of information, Amaro said.What people really want to knowfor example, vaccineand drug developersare the vulnerabilities that are present in this shield.

The computer simulations allowed Amaro and colleagues to create a cohesive picture of the spike protein that includes the glycans.

The reason why the computer resources at TACC are so important is that we can't understand what these glycans look like if we don't use simulation, Amaro said.

In order to animate the dynamics of the 1.7 million atom system under study, a lot of computing power was needed, said Amaro.

That's really where Frontera has been fantastic, because we need to sample relatively long dynamics, microsecond to millisecond timescales, to understand how this protein is actually working. We've been able to do that with Frontera and the COVID-19 HPC Consortium, Amaro said. Now we're trying to share our data with as many people as we can, because people want a dynamical understanding of what's happeningnot only with other academic groups, but also with different pharmaceutical and biotech companies that are conducting neutralizing antibody development, she said, adding that basic research is making a difference in winning the war against the SARS-Co-V-2 virus.

This research was supported by NIH (GM132826), NSF (RAPID MCB-2032054), an award from the RCSA Research Corp., a UC San Diego Moore's Cancer Center 2020 SARS-COV-2 seed grant, the Visible Molecular Cell Consortium and the Irish Research Council.

See the article here:
Sugar-Coating Disguise Allows for Coronavirus Infection - UC San Diego Health

Go back to high school with these classes on anatomy and physiology – Boing Boing

If youre looking to launch a new career, youll often see us present education course packages that will help you become a web developer or a project manager or a graphic designer. While theyre all very respectable career options, those professions dont present the same hands-on satisfaction or visceral sense of accomplishment that comes from actually repairing a human body.

While doctors often receive a lions share of the praise for putting ailing men and women on the mend, there are handfuls of healthcare professionals who play that role as well, including physical therapists, fitness experts, and kinesiologists.

It all starts with truly understanding the human body and how it works, which is at the heart of training like the Anatomy and Physiology for Beginners Course Bundle.

Whether you want a career in healthcare or just want to know why your body moves, acts and feels the way it does, these seven courses offer a smooth overview of various bodily systems and how they work together to make you, you.

Introduction to the Cardiovascular System goes right to the heart, explaining how that key organ pumps blood throughout your body as you get to know major structures and basic functions of the bodys transportation system. Meanwhile, Introduction to the Skeletal System provides a complete in-depth study of the skeletal system, the composition of your bones, and how they work with other organ systems.

Not to be outdone, Introduction to the Muscular System covers all 600 individual muscles, the 3 types of muscles in your body as well as the 5 types of muscle movements; and Introduction to the Respiratory System focuses on your lungs and how they redirect oxygen into your bloodstream.

Finally, introductions to the digestive, urinary and nervous systems zero in on the vital role each plays in your bodily operations, from understanding how digestive and immune systems work together, how urinary systems maintain body balance, and how the central and peripheral nervous system brings the whole body to movement and full operation.

Even just to take better care of yourself, this course bundle valued at over $200 packs vital information. Now with this offer, the entire collection is on sale for just $29.99.

Prices are subject to change.

Do you have your stay-at-home essentials? Here are some you may have missed.

Amazons new Chinese thermal spycam vendor was blacklisted by U.S. over allegations it helped China detain and monitor Uighurs and other Muslim minorities

Mark Di Stefano of the Financial Times is accused by The Independent of accessing private Zoom meetings held by The Independent and The Evening Standard as journalists were learning how coronavirus restrictions would affect them.

Hackers tried to break into the World Health Organization earlier in March, as the COVID-19 pandemic spread, Reuters reports. Security experts blame an advanced cyber-espionage hacker group known as DarkHotel. A senior agency official says the WHO has been facing a more than two-fold increase in cyberattacks since the coronavirus pandemic began.

When you hear the brand name Marshall, any music fan instantly conjures a single image: a classic Marshall stack. The amp has been synonymous with live performance since the 60s, with music artists of every stripe lining their stage sets with these thunderous cabinets. Even when you close your eyes, you can see them. The []

Were a latest and greatest kind of culture. We want the newest, shiniest, fastest piece of tech in existence and many are willing to pay top dollar for the privilege of saying no one owns one better. The reality is that life at the tech pinnacle is incredibly fleeting. Within months, sometimes weeks, even []

With no movies, concerts, or sporting events to get out and enjoy, the scope of your entertainment universe probably hasnt strayed too far beyond the edge of your sofa in months. And all that time living life on your A-1 piece of furniture has likely resulted in some unfortunate drink-related accidents. In this couch-based lifestyle, []

Read the original:
Go back to high school with these classes on anatomy and physiology - Boing Boing

POD: The anatomy of Leary’s commitment; Who might be next? – 247Sports

Hank South joins the pod to take Crimson Tide fans through the events that led up to Christian Leary's commitment to UA. Specifics include:

-- Roles played by Jeff Banks, Bryce Young and Jaylen Waddle in Leary's recruitment.

-- Another WR commitment working to add to UA's class, while another picks up fifth star.

-- Prospect(s) most likely to fill out Alabama's WR haul.

-- Commitment watch candidates.

-- Updating men's hoops transfer candidate Nike Sibande.

Continue reading here:
POD: The anatomy of Leary's commitment; Who might be next? - 247Sports

Anatomy of a Massachusetts nursing home catastrophe in the COVID-19 pandemic – World Socialist Web Site

By Julian James 19 June 2020

Massachusetts Republican Governor Charlie Baker ordered Phase II of the states reopening plan beginning June 8. The governors order gave the green light for a number of nonessential businesses and activities to resume, including day camps, funeral homes, public pools, golf courses, house cleaning services, retail stores and professional sports teams, among others. Casinos are also in talks with state officials about reopening on June 29.

Perhaps most significant is that the total ban on nursing home visits has been lifted, with requirements in place now that visitors meet residents outside and maintain social distancing. Indoor visits are now allowed in compassionate care and end of life scenarios. Massachusetts thus became the first state to open up nursing homes to nonresidents and staff, despite the fact roughly two-thirds of all COVID-19 deaths in the state occurred in nursing homes, 30 percent higher than the national average, as reported in late May.

The high-profile mass fatality events in Massachusetts nursing homes have shown an extreme level of unpreparedness. Most dangerous for staff and residents is the ongoing unavailability of sufficient amounts of effective Personal Protective Equipment (PPE) as well as access to testing. Systematic efforts to hide and downplay major outbreaks by state officials and nursing home administrators have also played a large role in facilities run by federal agencies, such as the US Department of Veterans Affairs (VA) as well as those run on a for-profit basis by corporations that in some cases operate hundreds of nursing homes.

One outbreak this past March at the VA-operated Soldiers Home in the small city of Holyoke in western Massachusetts previously reported on by the WSWS made national headlines and resulted in the deaths of 76 residents. Under the direction of superintendent Bennett Walsh, staff at the facility were denied proper PPE, and were ignored or bullied when they raised concerns about basic protocols not being followed, such as isolating residents who either had contracted the virus or were suspected of having contracted it. As growing numbers of staff called out of work after they became infected, a critical shortage of manpower led to orders from management to combine multiple floors in a single ward. This meant that residents would be packed together, ideal conditions for the spread of the disease.

The timeline and details of the deadly outbreak are instructive in that they expose the unwillingness of state officials to provide any serious assistance or make the information public, until public exposure forced their hand. Members of the Holyoke Board of Health became aware of the outbreak and deaths when a worker made contact on March 27 with Brenda Rodrigues, president of the local branch of the Service Employees International Union (SEIU). Rodrigues described the staff member as basically in tears as she related how there had been 11 deaths and that management was acting with reckless indifference.

Holyoke Mayor Alex Morse was alerted and placed a call the following day to Holyoke VA superintendent Walsh. Morse claims that Walsh admitted there had been deaths but downplayed them by mentioning that all the patients had preexisting conditions. Unsatisfied with what he described as Walshs clear lack of urgency, Morse was compelled to call State Secretary of the Massachusetts VA Francisco Urea. To the mayors dismay, Urea also seemed to downplay the situation. Morse followed up with a text to Massachusetts Lieutenant Governor Karyn Polito. Only then did officials with the Massachusetts Health and Human Services (HHS) respond by promising to send a task force to the facility.

When the news broke, Governor Baker claimed it was the first he had heard of the matter, and that he and other state officials had been left in the dark until contacted by Morse. The deputy secretary of the state Department of Health and Human Services (HHS) declared that superintendent Walsh was being placed on leave. The following Monday, Baker announced the launch of an investigation into the affair (the results of which have yet to be released), to focus in part on management and organizational oversight of the COVID-19 response in the Holyoke Soldiers Home ...

Roughly a month later, on May 26, Walshs lawyer convened a press conference in defense of his client, saying he would make public a series of emails and texts demonstrating Bennett had been in regular contact and sent updates to state authorities with regards to the deteriorating situation at the Soldiers Home. As to the real reason for his dismissal, Bennets attorney said, State officials were livid that Walsh had talked to local officials about the situation at the Soldiers Home without their prior approval ...

Upon their release, the emails and texts indeed showed Bennet appraising State officials of the situation, who declined to provide any serious assistance while simultaneously expressing confidence in the management of the Soldiers Home. In one emailsent five days before Bennetts suspensionan associate commissioner of the state HHS wrote Holyoke staff are doing everything they can and consistent with DPH recommendations.

Meanwhile, the staff was facing a critical shortage of PPE and manpower. Two days after receiving the email, Walsh contacted Urea on March to formally request he send National Guard Medics to assist with jobs that would normally be performed by medical staff. No such aid was forthcoming. Only after state officials were contacted by Holyoke Mayor Morse on March 28 did state HHS officials shift their response, taking command of operations at the Soldiers Home and sending a task force that included national guard medics. Bennett was immediately placed on administrative leave.

The case of the Veterans Home is only the most-high profile of many such incidents. Another large-scale outbreak hidden from local authorities occurred in late March at the Life Care Center of Nashoba Valley , a for-profit care home in Littleton, Massachusetts. As was the case at the VA hospital in Holyoke, staff were not being provided with proper PPE and protocols to stem the rampant spread of the virus.

Meanwhile, local officials were kept in the dark by nursing home administrators. Town officials only became aware of the scope of the disaster after the fire department was called 18 times over a five-day stretch, transporting 16 patients from the facility to the hospital. That outbreak would ultimately result in the deaths of 26 residents. Maria Krier, a nurse at the Nashoba Valley, who told a local news outlet after the first infection that nothing was being done to protect nurses and patients from the virus, succumbed to the disease after contracting it at the home.

Massachusetts saw at least six other towns and cities report additional outbreaks, each of which resulted in dozens of fatalities, including a staggering 66 deaths at the Leavitt Family Nursing Home in Longmeadow and 64 confirmed fatalities at the Mary Immaculate Nursing and Restorative Center in Lawrence.

At the time of the outbreaks, nursing homes were not legally required to report infections to residents or their families. Had such a directive been in place, members of the community may otherwise have intervened by removing their loved ones from what had become virtual deathtraps. Such a mandate for reporting was only issued by the Centers for Medicare and Medicaid Services on May 7, fully two months after deaths began mounting across the state.

Aside from the issue of transparency is the more fundamental question of government preparedness and the shortage of PPE, both of which remain unaddressed. Four months after Trump declared a national state of emergency, officials across the country have yet to equip medical professionals with sufficient amounts of protective equipment, nor has testing and contract tracing been implemented in line with even the most conservative estimates produced by scientists and health experts of what is needed.

For example, a research report published by the Harvard Global Health Initiative on April 20, authored by experts in public health, economics, and technology, used three different models to estimate the scale of testing that would be necessary in order to safely reopen the economy on a state-by-state basis. In the case of Massachusetts, around 65,000 daily tests would need to be performed according to the more conservative Los Alamos model before any reopening can be safely carried-out, while another estimate produced using the MIT model found that roughly 158,000 tests would be needed.

Despite this information being publicly available, Governor Baker has pushed ahead with his Four Phase reopening, implementing Phase I on May 18, when only 7,500 tests were being conducted per daya fraction of what is needed, according to the models. Three weeks later, at the time of Bakers Phase II re-opening on June 7, only around 10,000 daily tests were being conducted, a marginal increase. It should be noted that estimates for testing numbers were produced before tens if not hundreds of thousands of people throughout the state began attending large-scale protests in reaction to police violence and the murder of George Floyd in Minneapolis.

As in Massachusetts, all 50 states are now testing at levels falling dramatically short of what is needed. According to the authors of the Harvard Global Health Initiative report, We need to deliver 5 million tests per day by early June to deliver a safe social reopening. This number will need to increase over time (ideally by late July) to 20 million a day to fully remobilize the economy. We acknowledge that even this number may not be high enough to protect public health (emphasis added).

Had political leaders in the state and federal government taken this warning seriously and acted accordingly, over a quarter-of-a-million tests would now have been carried out in the US. As of June 12, the actual number of tests carried out, as cited by tracking site https://covidtracking.com/data, totaled around 22 thousand, or 9 percent of what is needed according to the Harvard researchers.

Instead of investing resources in a massive scaling-up of testing and contract tracing infrastructure, Governor Baker, like his Republican and Democratic counterparts across the country, has been enacting plans to send millions of people back to work while their children return to daycare centers and summer camps. These workers, youth and children will have no way of knowing whether they and their families are being exposed to the deadly virus.

Baker claimscontrary to realitythat he is making decisions based on the data and that he has been seeing positive trends for the past several weeks. While new deaths have indeed gone down from a single-day peak of 197 on April 26 to roughly a quarter of that figure at the time of this articles publication, the decrease has been achieved primarily through social distancing measures coupled with severe restrictions on nonessential businesses. Bakers Four-Phase reopening plan is now setting the stage for a drastic increase in COVID-19 cases. Baker tacitly acknowledged that possibility, saying the plan could be halted or rolled back if infections spike again.

The drive to reopen the economy in Massachusetts has been a thoroughly bipartisan affair. This was shown at a recent press event staged by the Massachusetts Nurses Association (MNA) featuring Democratic Senator Ed Markey. Donna Stern, regional director of the MNA said at the event, I call upon Charlie Baker to do the right thing. Now, hes done a lot of things right during this pandemic, and I do not want to take that away, but the one thing that he has not done, is stepped up, and stopped the egregious behavior of hospitals across the state she then appealed to Markey to place a phone call to the governor and insist he halt the imminent closure of a vital psychiatric hospital.

A WSWS reporter at the scene was able to ask the long-serving senator in front of news cameras why anyone should trust Governor Baker to safeguard public health, considering he was pushing ahead with his Four Phase plan without adequate testing and contact tracing. Markey responded by avoiding any criticism of Baker. The Democratic senator instead professed that The question isnt when we open, its how we open, so we clearly need sufficient testing, sufficient contact tracing ... [so that] public health is truly protected. Three days later, in an interview with the National Public Radio member station Northeast Public Radio, Markey was able to more clearly express his opinion, saying, We have to listen to the scientists and base our steps on science and medical expertise ... We have to walk the line. I think the governor is trying to do that, and hopefully we can be successful in achieving those goals.

Whether through omission, obfuscation or outright lies, the entire political establishment is engaged in an effort to hide the dangers facing the population as they are driven back to their workplaces without basic measures. This is because, as previously explained by the WSWS, the ruling class views the COVID-19 pandemic, not as a health crisis, to be dealt with by the application of scientifically based measures, but as a blow to profit accumulation. While they seek to temporarily mitigate the loss of profits due to factory and workplace shutdowns via intervention by the Fed, the stocks that make up their fortunes represent claims that must be supported by the extraction of surplus value from workers.

However, the working class will have its say in the course of these developments. The homicidal policies of the entire ruling class, assisted by its appendages in the mainstream media and among union bureaucrats, must be answered by the struggle of all workers, who should form rank-and-file committees completely independent of hostile class forces, armed with a socialist perspective.

Featured statements on the coronavirus pandemic

Continue reading here:
Anatomy of a Massachusetts nursing home catastrophe in the COVID-19 pandemic - World Socialist Web Site